Economics and Reimbursement for Spine Technologies

Jordana Schmier, Michael Halpern

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter discusses health economics and cost analyses in the context of evaluation of spine technologies. There are three principal methods for evaluating the cost-effectiveness (that is, costs and outcomes) of an intervention: prospective studies, database analysis, and modeling. Often, these methods are used in combination to provide complete information on cost-effectiveness. Prospective evaluation of cost-effectiveness can be performed in two settings. First, the costs and benefits of a therapy can be evaluated as part of a clinical trial. Cost-effectiveness can also be evaluated in prospective "naturalistic" studies. Databases used for cost-effectiveness analyses can include medical claims from public or private insurance providers, or databases from registries, health surveys, or other naturalistic prospective studies. Each data source has advantages and disadvantages, which are outlined in the chapter. Additional research needs to be conducted into the cost of other related conditions, to justify the costs associated with preventive and therapeutic technologies.

Original languageEnglish (US)
Title of host publicationSpine Technology Handbook
PublisherElsevier Inc.
Pages509-527
Number of pages19
ISBN (Print)9780123693907
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Cost effectiveness
Economics
Costs
Insurance
Health

ASJC Scopus subject areas

  • Chemical Engineering(all)

Cite this

Schmier, J., & Halpern, M. (2006). Economics and Reimbursement for Spine Technologies. In Spine Technology Handbook (pp. 509-527). Elsevier Inc.. https://doi.org/10.1016/B978-012369390-7/50017-4

Economics and Reimbursement for Spine Technologies. / Schmier, Jordana; Halpern, Michael.

Spine Technology Handbook. Elsevier Inc., 2006. p. 509-527.

Research output: Chapter in Book/Report/Conference proceedingChapter

Schmier, J & Halpern, M 2006, Economics and Reimbursement for Spine Technologies. in Spine Technology Handbook. Elsevier Inc., pp. 509-527. https://doi.org/10.1016/B978-012369390-7/50017-4
Schmier J, Halpern M. Economics and Reimbursement for Spine Technologies. In Spine Technology Handbook. Elsevier Inc. 2006. p. 509-527 https://doi.org/10.1016/B978-012369390-7/50017-4
Schmier, Jordana ; Halpern, Michael. / Economics and Reimbursement for Spine Technologies. Spine Technology Handbook. Elsevier Inc., 2006. pp. 509-527
@inbook{f6e0067e301345f79f082b93b6cbaeb8,
title = "Economics and Reimbursement for Spine Technologies",
abstract = "This chapter discusses health economics and cost analyses in the context of evaluation of spine technologies. There are three principal methods for evaluating the cost-effectiveness (that is, costs and outcomes) of an intervention: prospective studies, database analysis, and modeling. Often, these methods are used in combination to provide complete information on cost-effectiveness. Prospective evaluation of cost-effectiveness can be performed in two settings. First, the costs and benefits of a therapy can be evaluated as part of a clinical trial. Cost-effectiveness can also be evaluated in prospective {"}naturalistic{"} studies. Databases used for cost-effectiveness analyses can include medical claims from public or private insurance providers, or databases from registries, health surveys, or other naturalistic prospective studies. Each data source has advantages and disadvantages, which are outlined in the chapter. Additional research needs to be conducted into the cost of other related conditions, to justify the costs associated with preventive and therapeutic technologies.",
author = "Jordana Schmier and Michael Halpern",
year = "2006",
doi = "10.1016/B978-012369390-7/50017-4",
language = "English (US)",
isbn = "9780123693907",
pages = "509--527",
booktitle = "Spine Technology Handbook",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Economics and Reimbursement for Spine Technologies

AU - Schmier, Jordana

AU - Halpern, Michael

PY - 2006

Y1 - 2006

N2 - This chapter discusses health economics and cost analyses in the context of evaluation of spine technologies. There are three principal methods for evaluating the cost-effectiveness (that is, costs and outcomes) of an intervention: prospective studies, database analysis, and modeling. Often, these methods are used in combination to provide complete information on cost-effectiveness. Prospective evaluation of cost-effectiveness can be performed in two settings. First, the costs and benefits of a therapy can be evaluated as part of a clinical trial. Cost-effectiveness can also be evaluated in prospective "naturalistic" studies. Databases used for cost-effectiveness analyses can include medical claims from public or private insurance providers, or databases from registries, health surveys, or other naturalistic prospective studies. Each data source has advantages and disadvantages, which are outlined in the chapter. Additional research needs to be conducted into the cost of other related conditions, to justify the costs associated with preventive and therapeutic technologies.

AB - This chapter discusses health economics and cost analyses in the context of evaluation of spine technologies. There are three principal methods for evaluating the cost-effectiveness (that is, costs and outcomes) of an intervention: prospective studies, database analysis, and modeling. Often, these methods are used in combination to provide complete information on cost-effectiveness. Prospective evaluation of cost-effectiveness can be performed in two settings. First, the costs and benefits of a therapy can be evaluated as part of a clinical trial. Cost-effectiveness can also be evaluated in prospective "naturalistic" studies. Databases used for cost-effectiveness analyses can include medical claims from public or private insurance providers, or databases from registries, health surveys, or other naturalistic prospective studies. Each data source has advantages and disadvantages, which are outlined in the chapter. Additional research needs to be conducted into the cost of other related conditions, to justify the costs associated with preventive and therapeutic technologies.

UR - http://www.scopus.com/inward/record.url?scp=84882538764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882538764&partnerID=8YFLogxK

U2 - 10.1016/B978-012369390-7/50017-4

DO - 10.1016/B978-012369390-7/50017-4

M3 - Chapter

AN - SCOPUS:84882538764

SN - 9780123693907

SP - 509

EP - 527

BT - Spine Technology Handbook

PB - Elsevier Inc.

ER -